According to our (Global Info Research) latest study, the global Rapid Oral Fluid Drug Testing market size was valued at US$ 266 million in 2025 and is forecast to a readjusted size of US$ 348 million by 2032 with a CAGR of 4.0% during review period.
More and more customers across all industries are moving to oral fluid testing for the many advantages it provides. Rapid oral fluid screening offers an ideal solution that is less invasive than other methods of testing and can be administered anytime and anywhere. The use of oral fluid as a testing matrix offers numerous benefits. The process is less invasive, the collection can be fully observed without privacy concerns, tests can be administered without the need for specialized collection facilities and, most significantly, is resistant to adulteration.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Rapid oral fluid drug testing is an innovative technology that has seen significant growth in both medical and legal fields. As societal concerns surrounding drug abuse continue to rise, this market is expanding rapidly. Rapid oral fluid drug testing offers a convenient, non-invasive way to detect within minutes whether an individual has used specific drugs such as marijuana, cocaine, amphetamines, and more.
This report is a detailed and comprehensive analysis for global Rapid Oral Fluid Drug Testing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rapid Oral Fluid Drug Testing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rapid Oral Fluid Drug Testing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rapid Oral Fluid Drug Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Rapid Oral Fluid Drug Testing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rapid Oral Fluid Drug Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rapid Oral Fluid Drug Testing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Premier Biotech, OraSure Technologies, Quest Diagnostics, Neogen Corporation, Oranoxis Inc, Securetec Detektions-Systeme, Prometheusbio, Guangzhou Wondfo Biotech, Cell Projects, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rapid Oral Fluid Drug Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Consumables
Equipment
Market segment by Application
Workplace Testing
Criminal Justice Testing
Rehabilitation Therapy
Others
Major players covered
Abbott Laboratories
Premier Biotech
OraSure Technologies
Quest Diagnostics
Neogen Corporation
Oranoxis Inc
Securetec Detektions-Systeme
Prometheusbio
Guangzhou Wondfo Biotech
Cell Projects
Draeger
Salimetrics
Oasis Diagnostics
Lin-Zhi International
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid Oral Fluid Drug Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapid Oral Fluid Drug Testing, with price, sales quantity, revenue, and global market share of Rapid Oral Fluid Drug Testing from 2021 to 2026.
Chapter 3, the Rapid Oral Fluid Drug Testing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid Oral Fluid Drug Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Rapid Oral Fluid Drug Testing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapid Oral Fluid Drug Testing.
Chapter 14 and 15, to describe Rapid Oral Fluid Drug Testing sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Rapid Oral Fluid Drug Testing. Industry analysis & Market Report on Rapid Oral Fluid Drug Testing is a syndicated market report, published as Global Rapid Oral Fluid Drug Testing Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Rapid Oral Fluid Drug Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.